OptimizeRx (OPRX) Cash from Operations (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Cash from Operations data on file, last reported at 467000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations fell 112.09% year-over-year to 467000.0; the trailing twelve-month figure through Mar 2026 stood at 14384000.0 (up 116.79% YoY), and the FY2025 full-year result was 18715000.0, up 282.8% from the prior year.
• Cash from Operations eased to 467000.0 in Q1 2026, from 7088000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 7088000.0 in Q4 2025 to a low of 6258000.0 in Q4 2023.
• A 5-year average of 1561828.12 and a median of 1791000.0 in 2024 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations plunged 868.84% in 2023 and surged 3479.8% in 2025, its largest moves.
• Tracing OPRX's Cash from Operations over 5 years: stood at 2803484.0 in 2022, then slumped by 323.22% to 6258000.0 in 2023, then soared by 103.16% to 198000.0 in 2024, then surged by 3479.8% to 7088000.0 in 2025, then slumped by 106.59% to 467000.0 in 2026.
• Business Quant data shows OPRX's Cash from Operations at 467000.0 in Q1 2026, 7088000.0 in Q4 2025, and 3202000.0 in Q3 2025.